We analyzed the metabolites selected as biomarkers for FMC to support a hypothesis that these are significantly related to the cancer development process. Below we show the pathways to which these metabolites are involved. The list of metabolites was inputted to MetaboAnalyst and the program analyzed the pathways corresponding to the metabolites submitted. The most relevant pathways had larger points on the graph (Figure ). Below we discuss the relation to cancer of these pathways involved.